Risk of malignancies in patients with inflammatory bowel disease who used thiopurines as compared with other indications: a territory-wide study.

Kelvin Yu-Chen ZhengChuan-Guo GuoIrene O L WongLijia ChenHo Yin ChungKa Shing CheungWai K Leung

Published in: Therapeutic advances in gastroenterology (2020)

IBD patients in Hong Kong who used thiopurines had 2.37-fold increase in risk of malignancies than the general population, which was higher than non-users and different from thiopurine users for other indications.

Keyphrases

patients with inflammatory bowel disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
patient reported